Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E
Accident and Emergency Department, Royal Liverpool Children's NHS Trust, Alder Hey, UK.
Dev Med Child Neurol. 1995 Aug;37(8):682-8. doi: 10.1111/j.1469-8749.1995.tb15014.x.
Lorazepam was compared with diazepam for the treatment of acute convulsions and status epilepticus in 102 children in a prospective, open, 'odd and even dates' trial. Convulsions were controlled in 76 per cent of patients treated with a single dose of lorazepam and 51 per cent of patients treated with a single dose of diazepam. Significantly fewer patients treated with lorazepam required additional anticonvulsants to terminate the seizure. Respiratory depression occurred in 3 per cent of lorazepam-treated patients and 15 per cent of diazepam-treated patients. No patient who received lorazepam required admission to the intensive care unit for either respiratory depression or persisting status epilepticus. Rectally administered lorazepam appeared to be particularly valuable (100 per cent efficacy) when venous access was not possible.
在一项前瞻性、开放性、“奇偶数日期”试验中,对102名儿童使用劳拉西泮与地西泮治疗急性惊厥和癫痫持续状态进行了比较。单剂量劳拉西泮治疗的患者中76%惊厥得到控制,单剂量地西泮治疗的患者中这一比例为51%。接受劳拉西泮治疗的患者中需要额外使用抗惊厥药物来终止发作的明显较少。接受劳拉西泮治疗的患者中有3%出现呼吸抑制,接受地西泮治疗的患者中有15%出现呼吸抑制。接受劳拉西泮治疗的患者中没有因呼吸抑制或持续性癫痫持续状态而需要入住重症监护病房的。当无法建立静脉通路时,直肠给药的劳拉西泮似乎特别有价值(疗效达100%)。